The prodrome and clinical risk for psychotic disorders
- PMID: 24012073
- PMCID: PMC4140174
- DOI: 10.1016/j.chc.2013.04.002
The prodrome and clinical risk for psychotic disorders
Abstract
The psychosis prodrome offers great promise for identifying neural mechanisms involved in psychotic disorders and offers an opportunity to implement empirical interventions to delay, and ultimately ameliorate, illness onset. This article summarizes the literature on individuals in the putatively prodromal phase of psychosis/deemed at clinical high risk (CHR) for psychosis onset. Standardized measurement and manifestation of the CHR syndromes are discussed, followed by empirical findings that highlight the psychological deficits and biological abnormalities seen in CHR syndromes and psychotic disorders. Current controversies surrounding the diagnosis of CHR syndromes and issues related to the treatment of CHR individuals are also presented.
Keywords: Clinical high risk; Prodrome; Psychosis; Schizophrenia.
Copyright © 2013 Elsevier Inc. All rights reserved.
References
-
- Murray CJL, Lopez AD. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge (MA): Harvard University Press; 1996.
-
- Yung AR, McGorry PD. The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull. 1996;22:353–70. - PubMed
-
- Addington J, Heinssen R. Prediction and prevention of psychosis in youth at clinical high risk. Annu Rev Clin Psychol. 2012;8:269–89. - PubMed
-
- O’Donovan MC, Craddock NJ, Owen MJ. Genetics of psychosis; insights from views across the genome. Hum Genet. 2009;126:3–12. - PubMed
-
- Buka SL, Fan AP. Association of prenatal and perinatal complications with subsequent bipolar disorder and schizophrenia. Schizophr Res. 1999;39:113–9. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
